Gene · 8473
Papers4,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| O-GlcNAc glycans in the mammalian extracellular environment. | Carbohydr Res | 2025 | 39813972 | PubTator, text mining | PubMed |
| Genetic gradual reduction of OGT activity unveils the essential role of O-GlcNAc in the mouse embryo. | PLoS Genet | 2025 | 39787076 | PubTator, text mining | PubMed |
| Antioxidant taurine inhibits chondrocyte ferroptosis through upregulation of OGT/Gpx4 signaling in osteoarthritis induced by anterior cruciate ligament transection. | J Adv Res | 2025 | 39778769 | PubTator, text mining | PubMed |
| hsa-mir-483-3p modulates delayed breast cancer recurrence. | Sci Rep | 2025 | 39753688 | PubTator, text mining | PubMed |
| Upregulation of OGT-mediated EZH2 O-GlcNAcylation Promotes Human Umbilical Vein Endothelial Cell Proliferation, Invasion, Migration, and Tube Formation in Gestational Diabetes Mellitus. | Cell Biochem Biophys | 2025 | 39751742 | PubTator, text mining | PubMed |
| Implications and mechanisms of O-GlcNAcylation in cancer therapy resistance. | Tumori | 2025 | 39718082 | PubTator, text mining | PubMed |
| Covalent Proximity Inducers. | Chem Rev | 2025 | 39692621 | PubTator, text mining | PubMed |
| JUNB O-GlcNAcylation-Mediated Promoter Accessibility of Metabolic Genes Modulates Distinct Epithelial Lineage in Pulmonary Fibrosis. | Adv Sci (Weinh) | 2025 | 39676507 | PubTator, text mining | PubMed |
| O-GlcNAcylation stabilized WTAP promotes GBM malignant progression in an N6-methyladenosine-dependent manner. | Neuro Oncol | 2025 | 39671515 | PubTator, text mining | PubMed |
| Dynamic O-GlcNAcylation coordinates etoposide-triggered tumor cell pyroptosis by regulating p53 stability. | J Biol Chem | 2025 | 39667498 | PubTator, text mining | PubMed |
| OGT mediated HDAC5 O-GlcNAcylation promotes osteogenesis by regulating the homeostasis of epigenetic modifications and proteolysis. | J Orthop Translat | 2025 | 39659899 | PubTator, text mining | PubMed |
| O-GlcNAcylation of progranulin promotes hepatocellular carcinoma proliferation. | Biochem Biophys Res Commun | 2025 | 39657353 | PubTator, text mining | PubMed |
| Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity. | Cancer Cell | 2025 | 39642888 | PubTator, text mining | PubMed |
| O-GlcNAcylation in ovarian tumorigenesis and its therapeutic implications. | Transl Oncol | 2025 | 39616984 | PubTator, text mining | PubMed |
| Uncovering the intricacies of O-GlcNAc modification in cognitive impairment: New insights from regulation to therapeutic targeting. | Pharmacol Ther | 2025 | 39603350 | PubTator, text mining | PubMed |
| β-Ketoenamine covalent organic framework nanoplatform combined with immune checkpoint blockade via photodynamic immunotherapy inhibit glioblastoma progression. | Bioact Mater | 2025 | 39584065 | PubTator, text mining | PubMed |
| PERM1 regulates mitochondrial energetics through O-GlcNAcylation in the heart. | J Mol Cell Cardiol | 2025 | 39581161 | PubTator, text mining | PubMed |
| Curcumin inhibits the progression of hyperlipidemia via OGT mediated O-GlcNAcylation modulation of APOC3. | Int Immunopharmacol | 2025 | 39579540 | PubTator, text mining | PubMed |
| Spatiotemporal control of subcellular O-GlcNAc signaling using Opto-OGT. | Nat Chem Biol | 2025 | 39543398 | PubTator, text mining | PubMed |
| Photoactivatable O-GlcNAc Transferase Library Enables Covalent Chemical Capture of Solvent-Exposed TPR Domain Interactions. | Chembiochem | 2025 | 39541256 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8473/papers?page=17